186 related articles for article (PubMed ID: 8910943)
1. Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance.
Jaeken J; Pirard M; Adamowicz M; Pronicka E; van Schaftingen E
Pediatr Res; 1996 Nov; 40(5):764-6. PubMed ID: 8910943
[TBL] [Abstract][Full Text] [Related]
2. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency.
de Koning TJ; Dorland L; van Diggelen OP; Boonman AM; de Jong GJ; van Noort WL; De Schryver J; Duran M; van den Berg IE; Gerwig GJ; Berger R; Poll-The BT
Biochem Biophys Res Commun; 1998 Apr; 245(1):38-42. PubMed ID: 9535779
[TBL] [Abstract][Full Text] [Related]
3. Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts.
Sharma V; Ichikawa M; He P; Scott DA; Bravo Y; Dahl R; Ng BG; Cosford ND; Freeze HH
J Biol Chem; 2011 Nov; 286(45):39431-8. PubMed ID: 21949237
[TBL] [Abstract][Full Text] [Related]
4. Plasma lysosomal enzyme activities in congenital disorders of glycosylation, galactosemia and fructosemia.
Michelakakis H; Moraitou M; Mavridou I; Dimitriou E
Clin Chim Acta; 2009 Mar; 401(1-2):81-3. PubMed ID: 19100247
[TBL] [Abstract][Full Text] [Related]
5. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.
Van Schaftingen E; Jaeken J
FEBS Lett; 1995 Dec; 377(3):318-20. PubMed ID: 8549746
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency).
Carchon H; Van Schaftingen E; Matthijs G; Jaeken J
Biochim Biophys Acta; 1999 Oct; 1455(2-3):155-65. PubMed ID: 10571009
[TBL] [Abstract][Full Text] [Related]
7. Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib).
Schollen E; Dorland L; de Koning TJ; Van Diggelen OP; Huijmans JG; Marquardt T; Babovic-Vuksanovic D; Patterson M; Imtiaz F; Winchester B; Adamowicz M; Pronicka E; Freeze H; Matthijs G
Hum Mutat; 2000 Sep; 16(3):247-52. PubMed ID: 10980531
[TBL] [Abstract][Full Text] [Related]
8. A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
Zhang W; James PM; Ng BG; Li X; Xia B; Rong J; Asif G; Raymond K; Jones MA; Hegde M; Ju T; Cummings RD; Clarkson K; Wood T; Boerkoel CF; Freeze HH; He M
Clin Chem; 2016 Jan; 62(1):208-17. PubMed ID: 26430078
[TBL] [Abstract][Full Text] [Related]
9. A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation.
Chu J; Mir A; Gao N; Rosa S; Monson C; Sharma V; Steet R; Freeze HH; Lehrman MA; Sadler KC
Dis Model Mech; 2013 Jan; 6(1):95-105. PubMed ID: 22899857
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption.
Helander A; Jaeken J; Matthijs G; Eggertsen G
Clin Chim Acta; 2014 Apr; 431():15-8. PubMed ID: 24508628
[TBL] [Abstract][Full Text] [Related]
11. Combined PMM2-CDG and hereditary fructose intolerance in a patient with mild clinical presentation.
Hong X; Edmondson AC; Strong A; Pomerantz D; Michl E; Berry G; He M
Mol Genet Metab; 2023 Nov; 140(3):107682. PubMed ID: 37597336
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity.
Freeze HH; Aebi M
Biochim Biophys Acta; 1999 Oct; 1455(2-3):167-78. PubMed ID: 10571010
[TBL] [Abstract][Full Text] [Related]
13. Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation.
Cylwik B; Naklicki M; Chrostek L; Gruszewska E
Acta Biochim Pol; 2013; 60(2):151-61. PubMed ID: 23730680
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency).
Barone R; Carchon H; Jansen E; Pavone L; Fiumara A; Bosshard NU; Gitzelmann R; Jaeken J
J Inherit Metab Dis; 1998 Apr; 21(2):167-72. PubMed ID: 9584269
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities.
Acarregui MJ; George TN; Rhead WJ
J Pediatr; 1998 Nov; 133(5):697-700. PubMed ID: 9821433
[TBL] [Abstract][Full Text] [Related]
16. Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!
Jaeken J
J Inherit Metab Dis; 2003; 26(2-3):99-118. PubMed ID: 12889654
[TBL] [Abstract][Full Text] [Related]
17. Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I.
Mayatepek E; Schröder M; Kohlmüller D; Bieger WP; Nützenadel W
Acta Paediatr; 1997 Oct; 86(10):1138-40. PubMed ID: 9350901
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of malonate-based inhibitors of phosphosugar-metabolizing enzymes: class II fructose-1,6-bis-phosphate aldolases, type I phosphomannose isomerase, and phosphoglucose isomerase.
Desvergnes S; Courtiol-Legourd S; Daher R; Dabrowski M; Salmon L; Therisod M
Bioorg Med Chem; 2012 Feb; 20(4):1511-20. PubMed ID: 22269276
[TBL] [Abstract][Full Text] [Related]
19. Elevated carbohydrate-deficient transferrin (CDT) and its normalization on dietary treatment as a useful biochemical test for hereditary fructose intolerance and galactosemia.
Pronicka E; Adamowicz M; Kowalik A; Płoski R; Radomyska B; Rogaszewska M; Rokicki D; Sykut-Cegielska J
Pediatr Res; 2007 Jul; 62(1):101-5. PubMed ID: 17515832
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate-deficient glycoprotein syndromes: inborn errors of protein glycosylation.
Keir G; Winchester BG; Clayton P
Ann Clin Biochem; 1999 Jan; 36 ( Pt 1)():20-36. PubMed ID: 10370757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
